Subcutaneous drug delivery and the role of the lymphatics
- 30 May 2005
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today: Technologies
- Vol. 2 (1), 89-96
- https://doi.org/10.1016/j.ddtec.2005.05.006
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Lymphatic Absorption Is the Primary Contributor to the Systemic Availability of Epoetin Alfa following Subcutaneous Administration to SheepJournal of Pharmacology and Experimental Therapeutics, 2004
- Characteristics of a novel phospholipid-based depot injectable technology for poorly water-soluble drugsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2004
- Current status and potential application of ISCOMs in veterinary medicineAdvanced Drug Delivery Reviews, 2004
- Systemic Availability and Lymphatic Transport of Human Growth Hormone Administered by Subcutaneous InjectionJournal of Pharmaceutical Sciences, 2000
- Injection Site Effects on the Pharmacokinetics and Glucodynamics of Insulin Lispro and Regular InsulinDiabetes Care, 1996
- Targeting of colloids to lymph nodes: influence of lymphatic physiology and colloidal characteristicsAdvanced Drug Delivery Reviews, 1995
- The effect of subcutaneous injection site on absorption of human growth hormone: abdomen versus thighClinical Endocrinology, 1991
- Mechanisms causing initial lymphatics to expand and compress to promote lymph flow.Archives of Histology and Cytology, 1990
- ImmunolymphoscintigraphySeminars in Nuclear Medicine, 1989
- STUDIES ON THE PERMEABILITY OF LYMPHATIC CAPILLARIESThe Journal of cell biology, 1971